Thomas Dirschka

Summary

Publications

  1. ncbi [Ambulatory dermatologic surgery]
    T Dirschka
    Hautarztpraxis Wuppertal
    Hautarzt 56:457-65. 2005
  2. ncbi Mondor's disease: a rare cause of anterior chest pain
    Thomas Dirschka
    Dermatologic Practice Center, Wuppertal
    J Am Acad Dermatol 49:905-6. 2003
  3. doi An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids
    T Dirschka
    Private University Witten Herdecke, Faculty of Health, Witten Herdecke, Germany
    Clin Exp Dermatol 36:149-54. 2011
  4. ncbi Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses
    T Dirschka
    Dermatological Practice Center, Wuppertal, Germany
    J Eur Acad Dermatol Venereol 24:258-63. 2010
  5. ncbi [Surgical correction of scleroderma en coup de sabre]
    T Dirschka
    Dermatologische Praxis Wuppertal, Schuchardstrasse 15, 42275 Wuppertal, Germany
    Hautarzt 58:611-4. 2007
  6. ncbi [Efalizumab--therapy of moderately severe to severe plaque-psoriasis in the dermatologist's practice]
    Thomas Dirschka
    Dermatologische Praxis, Wuppertal, Germany
    J Dtsch Dermatol Ges 4:S3-S12. 2006
  7. ncbi [Multifocal penile intraepithelial neoplasia--targeted treatment with imiquimod]
    Thomas Dirschka
    Dermatologische Praxis, Wuppertal, Germany
    J Dtsch Dermatol Ges 4:559-62. 2006
  8. ncbi [75-year-old male with rapidly growing nodule on elbow]
    Thomas Dirschka
    Dermatologische Praxis, Wuppertal
    J Dtsch Dermatol Ges 4:256-9. 2006
  9. ncbi Impaired skin barrier and atopic diathesis in perioral dermatitis
    Thomas Dirschka
    Department of Experimental Dermatology, University of Witten Herdecke, Germany
    J Dtsch Dermatol Ges 1:199-203. 2003
  10. ncbi [Periocular dermatitis]
    Thomas Dirschka
    Institut für experimentelle Dermatologie der Universität Witten Herdecke
    J Dtsch Dermatol Ges 2:274-8. 2004

Detail Information

Publications18

  1. ncbi [Ambulatory dermatologic surgery]
    T Dirschka
    Hautarztpraxis Wuppertal
    Hautarzt 56:457-65. 2005
    ..Measures to promote quality assurance are also described. The difficult cost situation facing outpatient surgery is creating a need for new forms of cooperation between primary care physicians and hospitals...
  2. ncbi Mondor's disease: a rare cause of anterior chest pain
    Thomas Dirschka
    Dermatologic Practice Center, Wuppertal
    J Am Acad Dermatol 49:905-6. 2003
    ..Because pain precedes the typical clinical manifestation, problems of diagnosis can occur in the early phase of the illness...
  3. doi An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids
    T Dirschka
    Private University Witten Herdecke, Faculty of Health, Witten Herdecke, Germany
    Clin Exp Dermatol 36:149-54. 2011
    ..Blinded, controlled studies have found that oral alitretinoin is well tolerated and effective in the treatment of severe chronic hand eczema (CHE)...
  4. ncbi Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses
    T Dirschka
    Dermatological Practice Center, Wuppertal, Germany
    J Eur Acad Dermatol Venereol 24:258-63. 2010
    ..Actinic keratoses (AKs) are frequently diagnosed in dermatological patients. As they represent in situ carcinomas, effective treatment is required...
  5. ncbi [Surgical correction of scleroderma en coup de sabre]
    T Dirschka
    Dermatologische Praxis Wuppertal, Schuchardstrasse 15, 42275 Wuppertal, Germany
    Hautarzt 58:611-4. 2007
    ..The operation greatly improved the patient's daily life. The surgical therapy of scleroderma en coup de sabre offers an interesting therapeutic alternative...
  6. ncbi [Efalizumab--therapy of moderately severe to severe plaque-psoriasis in the dermatologist's practice]
    Thomas Dirschka
    Dermatologische Praxis, Wuppertal, Germany
    J Dtsch Dermatol Ges 4:S3-S12. 2006
    ..Therefore, a change of paradigm from the traditional therapy of inflammatory episodes to continuous control of psoriasis seems possible. This supplement deals with practical aspects of using efalizumab in the outpatient setting...
  7. ncbi [Multifocal penile intraepithelial neoplasia--targeted treatment with imiquimod]
    Thomas Dirschka
    Dermatologische Praxis, Wuppertal, Germany
    J Dtsch Dermatol Ges 4:559-62. 2006
    ..Local skin reactions such as erosions and edema of the glans accompanied by tingling and itching were well-tolerated by the patient. Imiquimod 5 % cream may represent an alternative local treatment option for multifocal PIN...
  8. ncbi [75-year-old male with rapidly growing nodule on elbow]
    Thomas Dirschka
    Dermatologische Praxis, Wuppertal
    J Dtsch Dermatol Ges 4:256-9. 2006
  9. ncbi Impaired skin barrier and atopic diathesis in perioral dermatitis
    Thomas Dirschka
    Department of Experimental Dermatology, University of Witten Herdecke, Germany
    J Dtsch Dermatol Ges 1:199-203. 2003
    ..We investigated skin barrier function and various markers of the atopic diathesis to elucidate their impact on the development of perioral dermatitis...
  10. ncbi [Periocular dermatitis]
    Thomas Dirschka
    Institut für experimentelle Dermatologie der Universität Witten Herdecke
    J Dtsch Dermatol Ges 2:274-8. 2004
    ..Perioral dermatitis paradoxically sometimes spares the entire perioral region. There may be isolated periocular involvement (periocular dermatitis)...
  11. ncbi Topical cosmetics and perioral dermatitis
    Thomas Dirschka
    Department of Experimental Dermatology, University of Witten Herdecke, Germany
    J Dtsch Dermatol Ges 2:194-9. 2004
    ..Perioral dermatitis (PD) is a common dermatological disease whose aetiology and pathogenesis remain speculative. Both cosmetics and topical corticosteroids have been implicated...
  12. ncbi Glove perforation in outpatient dermatologic surgery
    Thomas Dirschka
    Dermatologic Practice Center, Wuppertal, Germany
    Dermatol Surg 30:1210-2; discussion 1212-3. 2004
    ..Intact surgical gloves ensure protection of health-care employees and health-care recipients. Nevertheless, glove perforation is very common and puncture rates above 50% have been published in the literature...
  13. ncbi Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis
    T Dirschka
    Dermatological Practice Centre, Wuppertal, Germany
    Br J Dermatol 150:1136-41. 2004
    ..Rosacea and perioral dermatitis (PD) are common dermatoses, the aetiology and pathogenesis of which remain speculative. Objectives To investigate skin barrier function and features of atopy in both diseases...
  14. doi Optical coherence tomography: its role in daily dermatological practice
    Lutz Schmitz
    Facharzt für Dermatologie und Venerologie, Allergologie, Ambulante Operationen Schuchardstraße 15, 42275 Wuppertal, Germany
    J Dtsch Dermatol Ges 11:499-507. 2013
    ..There is a wide variety of indications for OCT. In addition to aiding in the diagnosis and clinical monitoring of inflammatory dermatoses, OCT is a very useful and feasible technique in dermato-oncology...
  15. ncbi [75-year-old male with persistent bilateral oedema of the eyelids]
    Thomas Dirschka
    Dermatologische Praxis, Wuppertal
    J Dtsch Dermatol Ges 5:937-9. 2007
  16. ncbi Primary oral sarcoidosis preceding Lofgren's syndrome
    Jochen Jackowski
    Department of Oral Surgery, School of Dental Medicine, University of Witten Herdecke, Germany
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:183-5. 2005
  17. ncbi Therapy of cutaneous squamous cell carcinoma in two retirement home residents
    Claus Oster-Schmidt
    J Dtsch Dermatol Ges 3:705-8. 2005
    ..In both cases, a comparable cosmetic result with full functional capacity of the hands was obtained. Imiquimod 5% cream was approved last year for the treatment of superficial basal cell carcinoma...
  18. ncbi The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies
    Siegfried Segaert
    Department of Dermatology, Katholieke Universiteit Leuven, Belgium
    J Dtsch Dermatol Ges 3:599-606. 2005
    ..Evidence-based studies are needed to determine the best way to manage these effects...